RenovoRx Inc Sustainability Reports
RenovoRx, Inc. is a clinical-stage biopharmaceutical company that develops targeted combination therapies for cancer treatment. The company utilizes its proprietary Trans-Arterial Micro-Perfusion (RenovoTAMP) platform to deliver chemotherapeutic agents directly to solid tumors.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG005XWWZL5
1 reports from 2023 to 2023